| Range: | 5.0-12.3 | Vol Avg: | 104626 | Last Div: | 0 | Changes: | -0.37 |
| Beta: | 1.76 | Cap: | 0.11B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Fri Oct 11 2024 | Empoloyees: | 58 | ||
| CUSIP: | 128126109 | CIK: | 0001736730 | ISIN: | US1281262089 | Country: | US |
| CEO: | Mr. Joshua Mandel-Brehm | Website: | https://www.camp4tx.com | ||||
CAMP 4.46 Stock Price CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Stock Details
Neutral 0.06
CAMP4 Reports Third Quarter 2024 Financial Results
- Completed Initial Public Offering (IPO) of common stock, raising gross proceeds of $82.1...
globenewswire.com·Thu Nov 21 2024
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow